ATLASWest Pharmaceutical Services (WST) earnings date: expected January 25–31
West Pharmaceutical Services (WST) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 25–31. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on WST
| Last price | $412.62 (-1.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.6% |
| Earnings beat history | Beat the EPS estimate in 6 of the last 6 reports |
| Dividend | $0.88 a year (0.21% yield) · next ex-date Nov 10, 2026 |
These figures come from the same calibrated model and valuation as the West Pharmaceutical Services stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 25–31 (estimate). One email the day before, with ATLAS’s read on West Pharmaceutical Services. You can switch it off at any time.
Alert me before WST reportsFree to start. Creating an account takes under a minute.
WST earnings at a glance
| Next report | Not announced · expected around January 25–31 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 6 reports) | 6 of 6 (100%) |
| Average EPS surprise | +30.3% |
| Average move around a report | ±4.6% (last 5) |
| Sector | Healthcare · Medical Instruments & Supplies |
The expected window is an ATLAS estimate: it takes the typical gap between West Pharmaceutical Services’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
West Pharmaceutical Services earnings history: last 6 reports
West Pharmaceutical Services last reported on Oct 29, 2026: EPS of $2.66 against an estimate of $2.18 (+22.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | $2.18 | $2.66 | +22.0% | Beat | – |
| Jul 23, 2026 | $2.08 | $2.37 | +13.9% | Beat | -8.4% |
| Jun 4, 2026 | $1.45 | $1.64 | +13.1% | Beat | -0.6% |
| Apr 23, 2026 | $1.68 | $2.13 | +26.8% | Beat | +11.6% |
| Feb 16, 2026 | -$10.85 | -$0.59 | +94.6% | Beat | -0.9% |
| Feb 12, 2026 | $1.83 | $2.04 | +11.5% | Beat | +1.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for WST
See the fair value, the probability range and the earnings history of West Pharmaceutical Services on its ATLAS page.
West Pharmaceutical Services (WST) stock analysisPlans from €3.99 a month.
West Pharmaceutical Services earnings: frequently asked questions
When is West Pharmaceutical Services (WST) next earnings date?
West Pharmaceutical Services has not announced its next report. Its last 4 reports came Oct 29, 2026, Jul 23, 2026, Apr 23, 2026, Feb 16, 2026, so ATLAS estimates the next one around January 25–31. This is an estimate based on that pattern, not a confirmed date.
How often does WST beat earnings estimates?
Of its last 6 reports with a recorded result, West Pharmaceutical Services beat the EPS estimate 6 times; the average surprise was +30.3%. Past results do not predict the next one.
How much does WST move around earnings?
Over its last 5 reports the stock moved an average of 4.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did West Pharmaceutical Services beat earnings estimates last quarter?
West Pharmaceutical Services last reported on Oct 29, 2026: EPS of $2.66 against an estimate of $2.18 (+22.0% surprise), a beat.
How much does WST usually move in a day?
On a normal trading day the ATLAS model puts WST’s one-day range at about ±1.6%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer